Office of Inspection and Investigations Foreign Unannounced Inspection Pilot | News Search

跳至主要内容

MedPath Trial Home

机构资讯 AI 研究

数据来源：ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

搜索试验。追踪管线。洞察审批。由 AI 驱动的临床研究情报平台。

产品

临床试验
药物情报
全球审批
深度研究
价格方案

资源

常见问题
搜索

公司

资讯
关于我们
联系我们

法律

隐私政策
服务条款

免责声明： 本网站提供信息检索和数据分析服务。内容不构成医疗建议。适应性评估仅供参考，不能替代合格医疗专业人员的咨询。数据来源于公共注册库和监管机构；MedPath 不保证数据的完整性或准确性。请以原始资料为准。

© 2026 MedPath Trial 版权所有

服务条款隐私政策

我们重视您的隐私

我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。

找到 598,543 条关于 “Office of Inspection and Investigations Foreign Unannounced Inspection Pilot”

FDA Expands Unannounced Inspections at Foreign Manufacturing Facilities to Level Global Oversight

FDA Launches One-Day Inspection Pilot Using AI to Target Low-Risk Manufacturing Facilities

FDA Issues Final Guidance on Bioresearch Monitoring Inspection Practices to Enhance Clinical Trial Oversight

Medicilon Successfully Passes FDA Inspection, Strengthening Global Preclinical R&D Capabilities

FDA Finalizes Guidance on Alternative Inspection Tools for Drug Manufacturing Facilities

Senate Hearing Exposes Systemic Failures in Generic Drug Supply Chain, Raising Safety Concerns for Millions of Americans

FDA Concludes Inspection of BioXcel's TRANQUILITY II Phase 3 Trial Site with VAI Status

Pennsylvania Hospital Inspection Reports: Tracking Safety Compliance at Chestnut Hill and Paoli Hospitals

Recce Pharmaceuticals Advances Phase 3 Diabetic Foot Infection Trial Following Clean Indonesian Regulatory Inspection

Lupin's Somerset Facility Receives FDA Establishment Inspection Report, Confirming Compliance

第 1 页，共 4083 页